Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
New anti-clotting drug gets FDA approval
Bristol-Myers Squibb and Pfizer received federal approval for their Eliquis drug to treat atrial fibrillation in patients facing risk of stroke or blood clots.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .